Drug profile · INN
carboprost tromethamine
CARBOPROST TROMETHAMINE
carboprost tromethamine (CARBOPROST TROMETHAMINE) is a prostanoid fp receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — carboprost tromethamine
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
carboprost tromethamine (CARBOPROST TROMETHAMINE) is a prostanoid fp receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Prostanoid FP receptor agonist
Primary target: Prostaglandin F2-alpha receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is carboprost tromethamine?
carboprost tromethamine (CARBOPROST TROMETHAMINE) is a prostanoid fp receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for carboprost tromethamine?
CARBOPROST TROMETHAMINE is a marketed brand name for carboprost tromethamine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of carboprost tromethamine?
carboprost tromethamine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.